Related references
Note: Only part of the references are listed.Empirical rescue therapy after Helicobacter pylori treatment failure:: a 10-year single-centre study of 500 patients
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice
D. Van Der Poorten et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Evolution of Helicobacter pylori therapy from a meta-analytical perspective
Javier P. Gisbert et al.
HELICOBACTER (2007)
Meta-analysis:: duration of first-line proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
Lorenzo Fuccio et al.
ANNALS OF INTERNAL MEDICINE (2007)
The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis
Angelo Zullo et al.
GUT (2007)
A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease
Anastassios Manolakis et al.
HELICOBACTER (2007)
American college of gastroenterology guideline on the management of Helicobacter pylori infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report
P. Malfertheiner et al.
GUT (2007)
Update on fluoroquinolone resistance in Helicobacter pylori:: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility
Vincent Cattoir et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Efficacy of rifabutin-based triple therapy in Helicobacter pylori infected patients after two standard treatments
Pedro Gonzalez Carro et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Eradication therapy for Helicobacter pylori
Nimish Vakil et al.
GASTROENTEROLOGY (2007)
Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium
Pierre Bogaerts et al.
HELICOBACTER (2006)
Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan
Hideyuki Miyachi et al.
HELICOBACTER (2006)
Systematic review and meta-analysis:: importance of CagA status for successful eradication of Helicobacter pylori infection
T. Suzuki et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
The effect of CYP2C19 polymorphisms on H-Pylori eradication rate in dual and triple first-line PPI therapies:: A meta-analysis
Sara Padol et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Smoking increases the treatment failure for Helicobacter pylori eradication
T Suzuki et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection:: A meta-analysis
RJ Saad et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Treatment of gastric mucosa-associated lymphoid tissue lymphoma:: Helicobacter pylori eradication and beyond
Carlos Montalban et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection
TJ Borody et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Risk factors associated with the development of intestinal metaplasia in first-degree relatives of gastric cancer patients
WK Leung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Meta-analysis:: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users
M Vergara et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Helicobacter pylori and MALT lymphoma
P Farinha et al.
GASTROENTEROLOGY (2005)
New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures:: a pilot study
LGV Coelho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Meta-analysis:: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication
MJR Janssen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients
A Qasim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Esomeprazole-based therapy in Helicobacter pylori eradication:: a meta-analysis
JP Gisbert et al.
DIGESTIVE AND LIVER DISEASE (2004)
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China -: A randomized controlled trial
BCY Wong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
H pylori antibiotic resistance:: prevalence, importance, and advances in testing
F Mégraud
GUT (2004)
Eradication therapy in Helicobacter pylori positive peptic ulcer disease:: Systematic review and economic analysis
AC Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Seven-day therapy for Helicobacter pylori in the United States
N Vakil et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication
H Fakheri et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Helicobacter pylori infection in Finland
H Rautelin et al.
ANNALS OF MEDICINE (2004)
Systematic review:: The effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis
AS Raghunath et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Effect of Helicobacter pylori infection and low-dose aspirin use on iron stores in the elderly
A Kaffes et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Review article:: the treatment of refractory Helicobacter pylori infection
F Mégraud et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Meta-analysis:: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication
DY Graham et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients
N Broutet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Levofloxacin - A review of its use in the treatment of bacterial infections in the United States
KF Croom et al.
DRUGS (2003)
A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication:: The QUADRATE study
PH Katelaris et al.
GASTROENTEROLOGY (2002)
Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia:: A 5-year follow-up study
D McNamara et al.
HELICOBACTER (2002)
Helicobacter species and hepatobiliary diseases
RWL Leong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies
WM Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection:: impact of two second-line therapies in a randomized study
U Peitz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Role of Helicobacter pylori infection and non-steroidal antiinflammatory drugs in peptic-ulcer disease:: a meta-analysis
JQ Huang et al.
LANCET (2002)
Helicobacter pylori and nonsteroidal anti-inflammatory drugs.: Approaching the end of the controversy in the new millennium, or room for more debate?
RWL Leong et al.
JOURNAL OF GASTROENTEROLOGY (2001)
A triple therapy regimen after failed Helicobacter pylori treatments
A Zullo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection
M Hojo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection
A Nagahara et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole
MJR Janssen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen
FKL Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Rifabutin-based Helicobacter pylori eradication 'rescue therapy'
F Canducci et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment -: Preliminary experience
H Bock et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole:: a meta-analysis of eradication of Helicobacter pylori
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Third line treatment for Helicobacter pylori:: a prospective, culture-guided study in peptic ulcer patients
F Gomollón et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Helicobacter pylori in the upper gastrointestinal tract: medical or surgical treatment of gastric lymphoma?
HD Roher et al.
LANGENBECKS ARCHIVES OF SURGERY (2000)
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy - A meta-analytical approach
MP Dore et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Share Paper
